Viewing Study NCT03202758


Ignite Creation Date: 2025-12-25 @ 12:00 AM
Ignite Modification Date: 2026-01-10 @ 3:27 PM
Study NCT ID: NCT03202758
Status: COMPLETED
Last Update Posted: 2023-02-10
First Post: 2017-06-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of the Safety and the Tolerability of Durvalumab Plus Tremelimumab Combined With FOLFOX in mCRC
Sponsor: Centre Georges Francois Leclerc
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: MEDI-TREME-COLON
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View